ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $0 | -100.0% | 200 | -88.2% | 0.00% | -100.0% |
Q4 2022 | $10 | -99.9% | 1,700 | -22.7% | 0.00% | 0.0% |
Q3 2022 | $14,000 | -94.0% | 2,200 | -90.0% | 0.00% | -93.8% |
Q2 2022 | $235,000 | -53.2% | 21,908 | -48.0% | 0.02% | -38.5% |
Q1 2022 | $502,000 | +148.5% | 42,156 | +81.6% | 0.03% | +225.0% |
Q4 2021 | $202,000 | +215.6% | 23,218 | +127.9% | 0.01% | +166.7% |
Q3 2021 | $64,000 | -52.2% | 10,187 | +107.9% | 0.00% | -57.1% |
Q2 2021 | $134,000 | +54.0% | 4,900 | -4.6% | 0.01% | +75.0% |
Q1 2021 | $87,000 | -89.7% | 5,134 | -86.5% | 0.00% | -90.2% |
Q4 2020 | $848,000 | +87.6% | 37,900 | +4.7% | 0.04% | +51.9% |
Q3 2020 | $452,000 | +35.7% | 36,202 | +13.4% | 0.03% | +22.7% |
Q2 2020 | $333,000 | +1565.0% | 31,938 | +930.3% | 0.02% | +2100.0% |
Q1 2020 | $20,000 | +53.8% | 3,100 | +40.9% | 0.00% | 0.0% |
Q4 2019 | $13,000 | +62.5% | 2,200 | +175.0% | 0.00% | 0.0% |
Q3 2019 | $8,000 | 0.0% | 800 | -11.1% | 0.00% | 0.0% |
Q2 2019 | $8,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |